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INTRODUCTION
Osteoarthrosis is the most prevalent joint disea-
se and is the main cause of functional incapacity(1,2) 
among elderly people(3). Knee osteoarthrosis is the 
fourth commonest cause of health problems among 
elderly women(4). The risk of incapacity consequent 
to osteoarthrosis alone is greater than from any other 
medical condition(3). Currently, there is no known 
cure for osteoarthrosis, and the aim of treatment is 
to improve pain, function and health-related quality 
of life, while minimizing the toxicity of the therapy 
whenever possible(3).
Osteoarthrosis is defined as failure of the joint car-
tilage resulting from mechanical, genetic, hormonal, 
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Advances in knowledge regarding the pathophysiology of 
pain among patients with knee osteoarthritis suggest that 
the central nervous system is involved as a source that 
maintains and amplifies the painful condition such that it is 
refractory to conventional orthopedic and rheumatological 
treatment. Initially, hyperalgesia is observed only at the 
affected site. However, when the pain becomes refractory, 
peripheral and central sensitization mechanisms contribute 
towards maintaining and amplifying the painful conditions, 
regardless of the peripheral process that originated the 
pain. At this stage, even removal of the etiological agent 
may no longer be enough to relieve the painful symptoms. 
It then becomes necessary to envisage that other factors, 
distant from the affected joint, may be responsible for the 
disabling painful condition in such patients. At present, 
osteoarthrosis does not have any known cure, and the aim 
of treatment is to lessen the pain while improving function 
and health-related quality of life, and whenever possible, to 
minimize the toxicity of the therapy. In the light of emer-
ging evidence suggesting that the central nervous system 
has a role in the physiopathology of pain in patients with 
knee arthrosis, the central nervous system should be taken 
into consideration as a therapeutic target, instead of only 
administering local treatment using ordinary analgesics, 
anti-inflammatory drugs and non-pharmacological mea-
sures. Thus, methods that modulate the spinal cord and 
cerebral cortex, including the use of antidepressants, may 
have a role in managing these patients.
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bone and metabolic factors, which gives rise to an 
imbalance between the degradation and synthesis of 
joint cartilage and subchondral bone. It is manifested 
by morphological, biochemical, molecular and biome-
chanical abnormalities of cells and the extracellular 
matrix, which lead to softening, fibrillation, ulceration 
and loss of the joint cartilage, and to sclerosis of the 
subchondral bone and formation of osteophytes and 
subchondral cysts.
PHYSIOPATHOLOGY
Despite deep knowledge of the physiopathology 
of arthrosis at molecular level, there is still little kno-
wledge about the genesis of pain in such patients. 
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Classically, it is known that the possible causes 
of pain in arthrosis are related to increased intra-
osseous pressure due to vascular congestion of the 
subchondral bone, growth of osteophytes, synovitis 
and inflammation, capsular fibrosis, contracture and 
muscle weakness.
In a previous study, we showed that hyperalge-
sia of central origin was responsible for 61% of the 
pain reported by such patients on self-assessment 
scales like the visual analogue pain scale, WOMAC 
(Western Ontario McMaster Osteoarthritis Index) and 
SF-36 (Medical Outcomes Study 36-item Short Form 
Health Survey)(5). This suggests that both the central 
nervous system and the peripheral system are proba-
bly involved in maintaining the state of chronic pain 
in these patients. It seems that initially, hypersensi-
tivity is only observed at the site affected. However, 
when the pain becomes refractory, mechanisms for 
central and peripheral sensitization start to contribute 
towards maintaining painful conditions, independent 
of the peripheral process that originated the pain.
Differently from acute pain, for which the phy-
siopathology is relatively well known and the the-
rapeutic results are more encouraging, chronic pain 
does not translate the magnitude of the tissue lesion 
and treatments remain unsatisfactory. Recently, de-
velopment of new diagnostic methods for clinical 
investigation of central sensitization has furnished 
new knowledge for better understanding of the phy-
siopathology of chronic pain. This new information 
has demonstrated that functional abnormalities in the 
central and peripheral nervous systems may play an 
important role in maintaining chronic pain.
Better comprehension of the complex mechanis-
ms involved in generating, modulating, amplifying 
and perpetuating pain has an important role in de-
termining the best therapeutic regimen to use in tre-
ating patients with knee arthrosis. Modern treatment 
for pain, for example, is no longer based solely on 
symptom relief but on controlling it based on the 
physiopathological mechanisms involved(6).
Recently, it was observed that intense and per-
sistent nociceptive stimuli coming from peripheral 
tissues could trigger neuroplastic abnormalities in 
the central nervous system(7,8). These abnormalities 
include increased excitability of the neurons in the 
posterior horn of the spinal cord, thus producing 
hyperalgesia, temporal summation of the pain and 
ascending regulation.
These neurochemical changes suggest that the 
pain induces and is partially maintained by a state of 
central sensitization(9), in which increased transmis-
sion of nociceptive information allows neurons that 
are not normally involved in transmitting pain infor-
mation to start to do so. In this way, stimuli such as 
pressure on certain parts of the body, which in healthy 
volunteers are not interpreted as painful, start to be 
perceived as such(5). It is worth emphasizing that pe-
ripheral nociceptive stimuli may begin and maintain 
the state of central sensitization, as has already been 
described in relation to fibromyalgia(7,10-12).
Although chronic painful symptoms are subjecti-
ve by nature, they may correlate with neuroimaging 
evidence that reveals increased levels of cerebral ac-
tivation responses(13-15).
Several authors have already demonstrated that 
central sensitization may be involved in the gene-
sis, maintenance, amplification and exacerbation of 
painful symptoms in patients with arthrosis in various 
body segments(15-19). Like in our study (Imamura
et al(5)), cutaneous and deep hyperalgesia has been 
observed in the forearms of patients with rhizarthro-
sis(17) and in the anterior tibial muscle of patients with 
knee arthrosis(19).
It is interesting to note that painful sites with lower 
tolerance of pressure present high levels of substance 
P, calcitonin, bradykinin, tumor necrosis factor, inter-
leukin-1, serotonin and norepinephrine, in comparison 
with healthy individuals without spontaneous pain or 
asymptomatic subjects(20). In individuals with spon-
taneous pain, areas distant from the painful site also 
demonstrate significant increases in the levels of these 
chemical mediators(21).
It is known that these abnormalities occur not only 
in the spinal cord(22), but also in other structures of 
the central nervous system. For example, a pilot stu-
dy has already revealed that areas of the brain were 
involved in pain processing in a group of 12 patients 
with knee osteoarthrosis(23). The results showed that 
the arthritis pain was associated with increased acti-
vity in the cingulate cortex, thalamus and amygdale, 
which are areas involved in processing the emotional 
aspects of pain(23).
The presence of peripheral and central sensitization 
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in patients with chronic pain induces additional neu-
roplastic changes in the posterior horn of the spinal 
cord and in cortical areas that then maintain and am-
plify the painful state, thus forming a vicious circle 
with refractory symptoms. At this stage, even removal 
of the etiological agent may no longer be enough to 
relieve the painful symptoms. It therefore becomes 
necessary to consider that other factors, distant from 
the joint that is affected, may be the agents respon-
sible for the painful and incapacitating symptoms in 
these patients(5,24), not only at the originating point(24), 
but also for central sensitization(5).
WARNING SIGNS FOR THE DIAGNOSIS 
OF PAIN IN KNEE ARTHROSIS: 
PHYSICAL EXAMINATION TIPS FOR 
ORTHOPEDISTS
Within this context, diagnosing peripheral and 
central sensitization is very important(25,26), because 
when this is present, it means that neurons of the 
posterior horn of the spinal cord that would normally 
only be activated by nociceptive stimuli can now be 
activated by other stimuli, including non-nociceptive 
stimuli. This phenomenon is widely known as allo-
dynia(27). This explains why, in cases in which central 
sensitization has become established, minimal peri-
pheral stimuli are sufficient to maintain the painful 
and incapacitating condition(8).
Warning signs are clinical indicators of problems 
that are more serious and which require greater 
medical attention. These signs were developed for 
use in cases of acute lumbalgia. However the same 
concepts can be applied in a more wide-ranging 
manner in searching for pain centers or localized 
hyperalgesia that has disseminated to parts of the 
body other than the knee region, and for increases 
in the size of painful areas. For example, the 
pressure needed to cause pain, applied to various 
parts of the body, is lower among these patients 
than among normal controls of the same gender and 
age(5). With sensitization of the localized pain areas 
and bombardment of the central nervous system 
with neuron impulses, the adjacent segments start 
to become progressively sensitized. One important 
finding is that the degree of increase in sensitization 
correlates with the pain level.
PAIN MANAGEMENT
In the light of this emerging evidence suggesting 
that the central nervous system has a role in the phy-
siopathology of pain among patients with knee ar-
throsis, the structures of the central nervous system 
should also be considered to be therapeutic targets, 
instead of administering purely local treatment with 
common analgesics, anti-inflammatory agents and 
non-pharmacological measures.
We often see patients who, despite undergoing cor-
rect orthopedic treatment, persistently present painful 
symptoms. These symptoms are generally segmental 
pains along the thigh and lower leg.
To understand these symptoms, we studied(5) oc-
currences of segmental pain in the region of the vastus 
medialis, long adductor, anterior tibial and peroneus 
longus muscles that was associated with cutaneous 
hyperalgesia in these regions, among 62 patients with 
knee osteoarthrosis who were awaiting treatment 
consisting of total arthroplasty. We found that these 
symptoms occurred more frequently among these pa-
tients than among 22 patients of the same sex and age 
who had not had any painful symptoms in the lower 
limbs for the past year (p < 0.001).
There is radiological evidence that persistent pain 
leads to atrophy of the cerebral cortex, and that this 
improves with adequate treatment for this pain. If 
the participation of the central nervous system in the 
genesis of chronic pain like the pain caused by knee 
arthrosis is neglected, a mechanism that might explain 
the persistent pain seen in up to 60% of such patients 
will remain unknown.
The use of physiotherapeutic means and centrally 
acting drugs such as antidepressants(28) needs to be 
taken into consideration in treating these patients.
FINAL REMARKS
In analyzing the pain presented by patients with 
knee arthrosis, which is pain that evolves chronically 
and is refractory to the usual orthopedic treatment, 
significant changes in cortical areas that are associa-
ted with affective and emotional processing need to 
be taken into consideration.
Among these patients, it is of fundamental impor-
tance to reduce or even to prevent amplification of the 
symptoms caused by continual activation of these areas.
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